Danaher Corporation (DHR) Stake Lowered by Mark Sheptoff Financial Planning LLC
Mark Sheptoff Financial Planning LLC lessened its position in Danaher Corporation (NYSE:DHR) by 0.1% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 1,952 shares of the conglomerate’s stock after selling 1 shares during the period. Mark Sheptoff Financial Planning LLC’s holdings in Danaher Corporation were worth $165,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its stake in shares of Danaher Corporation by 3.9% in the 1st quarter. Vanguard Group Inc. now owns 40,967,631 shares of the conglomerate’s stock worth $3,503,962,000 after acquiring an additional 1,530,015 shares during the period. BlackRock Inc. lifted its stake in shares of Danaher Corporation by 2,530.9% in the 1st quarter. BlackRock Inc. now owns 37,967,922 shares of the conglomerate’s stock worth $3,247,398,000 after acquiring an additional 36,524,795 shares during the period. FMR LLC lifted its stake in shares of Danaher Corporation by 0.3% in the 1st quarter. FMR LLC now owns 19,441,167 shares of the conglomerate’s stock worth $1,662,803,000 after acquiring an additional 53,429 shares during the period. Bank of New York Mellon Corp lifted its stake in shares of Danaher Corporation by 0.7% in the 1st quarter. Bank of New York Mellon Corp now owns 7,645,818 shares of the conglomerate’s stock worth $653,946,000 after acquiring an additional 50,673 shares during the period. Finally, Geode Capital Management LLC lifted its stake in shares of Danaher Corporation by 6.0% in the 1st quarter. Geode Capital Management LLC now owns 5,815,659 shares of the conglomerate’s stock worth $496,687,000 after acquiring an additional 329,458 shares during the period. Institutional investors own 75.68% of the company’s stock.
Several research firms have recently commented on DHR. Cowen and Company restated a “buy” rating and issued a $90.00 target price on shares of Danaher Corporation in a research note on Wednesday. Goldman Sachs Group, Inc. (The) restated a “neutral” rating and issued a $83.00 target price on shares of Danaher Corporation in a research note on Tuesday, September 26th. Wells Fargo & Company began coverage on shares of Danaher Corporation in a research note on Thursday, July 13th. They issued a “market perform” rating and a $90.00 target price for the company. Jefferies Group LLC restated a “buy” rating and issued a $95.00 target price on shares of Danaher Corporation in a research note on Friday, August 4th. Finally, BidaskClub cut shares of Danaher Corporation from a “sell” rating to a “strong sell” rating in a research note on Tuesday, August 1st. One investment analyst has rated the stock with a sell rating, four have given a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $92.44.
In other Danaher Corporation news, Director Linda P. Hefner sold 10,578 shares of the company’s stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $83.03, for a total value of $878,291.34. Following the completion of the sale, the director now directly owns 42,151 shares of the company’s stock, valued at approximately $3,499,797.53. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the company’s stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $81.78, for a total transaction of $799,154.16. Following the completion of the sale, the insider now directly owns 155,520 shares of the company’s stock, valued at $12,718,425.60. The disclosure for this sale can be found here. Insiders sold a total of 71,496 shares of company stock valued at $5,916,223 over the last three months. 12.20% of the stock is owned by corporate insiders.
ILLEGAL ACTIVITY WARNING: This news story was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of international trademark and copyright laws. The legal version of this news story can be read at https://www.thecerbatgem.com/2017/10/06/danaher-corporation-dhr-stake-lowered-by-mark-sheptoff-financial-planning-llc.html.
Danaher Corporation (DHR) opened at 86.97 on Friday. The stock has a 50 day moving average of $84.88 and a 200-day moving average of $84.18. The stock has a market cap of $60.42 billion, a P/E ratio of 27.76 and a beta of 1.03. Danaher Corporation has a one year low of $75.71 and a one year high of $88.62.
Danaher Corporation (NYSE:DHR) last posted its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, topping the consensus estimate of $0.97 by $0.02. The business had revenue of $4.51 billion during the quarter, compared to the consensus estimate of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.90 earnings per share. Analysts anticipate that Danaher Corporation will post $3.95 EPS for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 29th will be issued a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date is Thursday, September 28th. Danaher Corporation’s payout ratio is 17.83%.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.